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ABSTRACT  23 
We tested the hypothesis that type 2 diabetes (T2D) alters the profile of muscle fractional 24 
oxygen (O2) extraction (near-infrared spectroscopy) during incremental cycle exercise. 25 
Seventeen middle-aged individuals with uncomplicated T2D and 17 controls performed an 26 
upright ramp test to exhaustion. The rate of muscle deoxygenation (i.e. deoxygenated 27 
haemoglobin and myoglobin concentration, Δ[HHb+Mb]) profiles of the vastus lateralis muscle 28 
were normalised to 100% of the response, plotted against % power output (PO) and fitted with 29 
a double linear regression model. Peak oxygen uptake was significantly (P<0.05) reduced in 30 
individuals with T2D. The %Δ[HHb+Mb]/%PO slope of the first linear segment of the double 31 
linear regression function was significantly (P<0.05) steeper in T2D than controls (1.810.61 32 
vs 1.350.43). Both groups displayed a near-plateau in Δ[HHb+Mb] at an exercise intensity 33 
(%PO) not different among them. Such findings suggest that a reduced O2 delivery to active 34 
muscles is an important underlying cause of exercise intolerance during a maximum graded test 35 
in middle-aged individuals with T2D.  36 
 37 
Keywords: near-infrared spectroscopy, oxygen extraction, cycling, exercise tolerance, type 2 38 
diabetes 39 
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1. Introduction 41 
Individuals with uncomplicated type 2 diabetes mellitus (T2D) demonstrate impairments in 42 
peak exercise capacity (V̇O2peak), an established clinical predictor of cardiovascular and all-43 
cause mortality (Kodama et al., 2009; Swift et al., 2013), in the region of 20% (Baldi et al., 44 
2003; Kiely et al., 2015; Mac Ananey et al., 2011; O'Connor et al., 2015; O'Connor et al., 2012; 45 
Regensteiner et al., 1998). Importantly, this impairment is independent of obesity and age, and 46 
present in the absence of clinically apparent cardiovascular disease (Green et al., 2015). Whilst 47 
the precise mechanisms for this diminished exercise capacity remain to be elucidated, it is likely 48 
the consequence of a complex array of pathophysiological changes at a central and/or peripheral 49 
level (Green et al., 2015; Poitras et al., 2018). Maximum V̇O2, representative of the integration 50 
of the pulmonary, cardiovascular and muscular systems to uptake, transport and utilise O2 51 
respectively, is governed by the oxygen cascade from the environment to the muscle 52 
mitochondria (Poole, 1997; Wagner et al., 1997), and is thus, consequent to the product of 53 
whole-body perfusive and diffusive O2 conductance. However, most commonly, the Fick 54 
relationship is determined either at the pulmonary level, or across the exercising limb(s), and is 55 
representative of pooled fractional O2 extraction across multiple compartments which may not 56 
necessarily reflect the discrete adjustments of O2 exchange within the microvasculature of the 57 
active muscle (Iannetta et al., 2017; Okushima et al., 2016; Spencer et al., 2012). As such, 58 
considering the matching of O2 delivery (QO2)-to- V̇O2 and diffusive O2 conductance at the 59 
level of the active muscle vasculature during exercise is of great relevance when exploring the 60 
mechanistic bases for the decreased exercise tolerance observed in T2D. 61 
 62 
Substantial evidence exists to suggest that peripheral O2 delivery in the lower limbs is impaired 63 
in individuals with uncomplicated T2D. For instance, the maximum leg haemodynamic and 64 
vasodilatory responses during an incremental calf plantar-flexion exercise (Kiely et al., 2014) 65 
as well as steady-state femoral artery blood flow measurements during cycling (Kingwell et al., 66 
4 
 
2003) and knee extension exercise (Lalande et al., 2008) are reduced in men and women with 67 
uncomplicated T2D. Additionally, leg vascular conductance kinetics at the onset of heavy-68 
intensity plantar-flexion exercise (Kiely et al., 2014; MacAnaney et al., 2011), and quadriceps 69 
muscle microvascular blood flow kinetics during moderate cycling (Bauer et al., 2007) are 70 
impaired (i.e. slowed/blunted) in individuals with T2D free from cardiovascular disease. In 71 
contrast, Poitras et al. (2015) recently reported unaffected leg blood flow kinetics during knee 72 
extension/flexion exercise in individuals with T2D; although participants had a more advanced 73 
diabetes and history of cardiovascular disease, with their control group also having a similar 74 
history of cardiovascular disease/comorbidities (Poitras et al., 2015). In agreement with Poitras 75 
et al. (2015), Copp et al. (2010) found that locomotory muscle(s) blood flow during running 76 
was not decreased in the rat GK model of type 2 diabetes (Copp et al., 2010) despite grossly 77 
impaired microvascular perfusion at rest (Padilla et al., 2006). 78 
 79 
It is therefore plausible that the maldistribution of active muscle blood flow in individuals with 80 
uncomplicated T2D (Kiely et al., 2014; MacAnaney et al., 2011), and subsequently a decreased 81 
microvascular partial pressure of O2 (Pmvo2) (Padilla et al., 2007), would mandate an increased 82 
reliance on fractional O2 extraction in the exercising muscle in an effort to achieve a given 83 
increase in V̇O2. The use of near-infrared spectroscopy (NIRS) during exercise permits a non-84 
invasive assessment of microvascular O2 extraction (DeLorey et al., 2003). By measuring the 85 
concentration changes in deoxygenated haemoglobin and myoglobin (Δ[HHb+Mb]), an 86 
estimate of fractional O2 extraction is possible. NIRS, therefore, provides insights into the 87 
dynamic balance between regional QO2 and V̇O2 at the level of the microvasculature (Spencer 88 
et al., 2012), the determining factor for Pmvo2. Accordingly, investigating the dynamic response 89 
of [HHb+Mb] within the microcirculation of the exercising muscles during a ramp incremental 90 
test may offer insight into pathophysiological mechanisms potentially implicated in the reduced 91 
exercise capacity in T2D.  In the present study the profile of %Δ[HHb+Mb] during a ramp 92 
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incremental test was characterized using a function including two linear segments; the ‘double-93 
linear model’ (Vieth, 1989) as it has been proffered to best characterise this profile (Spencer et 94 
al., 2012). In the first segment, a linear increase in %Δ[HHb+Mb] relative to changes in work 95 
rate occurs, representing the increasing reliance on O2 extraction relative to metabolic demand. 96 
This culminates at a ‘breakpoint’ (Δ[HHb+Mb] – BP), from which a “plateau-like” response 97 
ensues despite the continued increase in work rate. The breakbpoint has been associated with 98 
transitions in exercise intensity domains between heavy to severe-intensity exercise (Bellotti et 99 
al., 2013; Keir et al., 2015). This plateau in the [HHb+Mb] signal does not indicate the upper 100 
limit of O2 extraction during incremental tests, and it seems to be connected to the re-101 
distribution of blood flow towards the active tissues once this upper boundary of exercise is 102 
achieved (Inglis et al., 2017). 103 
 104 
The aim of the present study was to explore the influence of T2D on the profile of local muscle 105 
fractional O2 extraction, as indicated by the NIRS-derived Δ[HHb+Mb] response. We 106 
hypothesized that individuals with T2D would display an accelerated muscle deoxygenation 107 
response throughout the ramp incremental exercise bout. This would be depicted by a steeper 108 
primary slope of the double linear equation, thereby signifying an increased dependence on O2 109 
extraction for providing adequate V̇O2 at a given work rate. To avoid the potential effects of 110 
aging on the T2D-related impairments on exercise tolerance previously established in men 111 
(O'Connor et al., 2015; Wilkerson et al., 2011) we limited the age of participants to < 55 yr. 112 
 113 
2. Methods 114 
2.1. Participants 115 
Thirty four individuals, 17 with uncomplicated T2D (12 males, 5 females), and 17 age- and 116 
BMI-matched controls (ND) (12 males, 5 females) volunteered to participate in this study. The 117 
age range of all participants was between 36 and 55 yr. (Table 1). Participants in the control 118 
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group (ND) were recruited from the general population, whilst participants with T2D were 119 
recruited from the diabetes outpatient clinics of St. Columcille’s Hospital (Louglinstown, Co. 120 
Dublin) and St. Vincent’s University Hospital (SVUH, Dublin 4), following chart review. Five 121 
female participants were premenopausal (2 T2D, 3 ND) and 5 were postmenopausal (3 T2D, 2 122 
ND) not undergoing hormone replacement therapy. All participants were non-smokers and had 123 
not smoked during the 12-month period preceding the study. Individuals with T2D had a 124 
clinical history of diabetes of between 2 to 9.5 years, with adequately controlled HbA1c levels 125 
(<10%) (Table 1) and were not taking insulin or beta-blockers. Two of the controls were on 126 
prescriptive medications (statins, n = 2), and with the exception of one participant, all 127 
participants with T2D were taking oral (n = 15) and/or subcutaneous (n =1) hypoglycaemic 128 
prescription medications (metformin monotherapy, n = 9; metformin & sulphonylurea, n = 3; 129 
metformin & thiazolidinedione, n = 1; glucagon-like peptide 1, n = 1; sodium glucose 130 
cotransporter 2 inhibitors, n = 4). In addition, a subgroup of individuals with T2D were taking 131 
antihypertensive prescription drugs (angiotensin converting enzyme inhibitor, n = 4; 132 
angiotensin II receptor blocker, n = 2; calcium channel blocker, n = 5) and statins (n =6).  133 
 134 
At the commencement of the present study, individuals with T2D displayed no clinical evidence 135 
of ischemic heart disease (normal ECG during treadmill stress test following the Bruce 136 
protocol), peripheral arterial disease (0.9 < ABI < 1.3), kidney dysfunction (urine protein < 137 
200mg/dl), or liver dysfunction (urine creatinine levels < 2.2 mg/dl). Participants were 138 
classified as physically inactive by self-report (≤1.5 h.week-1 of moderate-intensity exercise in 139 
the preceding 6 months), which was confirmed by the use of 5-day RT3 triaxial accelerometery 140 
(Stayhealthy Inc, CA) in a subset of participants (Table 1) (Rowlands et al., 2004). All 141 
participants provided written informed consent before commencement, and the study was 142 
approved by the Faculty of Health Sciences’ Research Ethics Committee, Trinity College 143 
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Dublin, and St Vincent’s Healthcare Ethics and Medical Research Committee, and conducted 144 
in accordance with the Declaration of Helsinki (2008). 145 
 146 
2.2. Study Protocol 147 
2.2.1. Overview.  148 
Following a satisfactory completion of the 12-lead ECG stress test, participants were tested on 149 
one occasion either at St. Columcille’s Hospital or the cardiovascular laboratory in Trinity 150 
College Dublin. Premenopausal participants were tested during the mid-follicular phase (days 151 
5-12) of the menstrual cycle. All participants refrained from consuming alcohol, caffeine and 152 
non-prescribed nutritional supplements in the 24 hours prior to testing and constrained their 153 
exercise to normal activities of daily living.  All participants performed a ramp incremental 154 
cycling test to exhaustion to determine V̇O2peak. 155 
 156 
2.2.2. Ramp incremental cycling tests to exhaustion. The ramp incremental cycling test to 157 
exhaustion was performed in an upright position on an electrically braked cycle ergometer 158 
(Excalibur Sport; Lode B.V., Groningen, The Netherlands). Exercise was performed at an initial 159 
workload of 10 W for 2 min. This was followed by 10-15 W.min-1 increments in PO in females 160 
or 10-25 W.min-1 increments in males (depending on stated activity levels), until volitional 161 
exhaustion. Pedal frequency was held constant at an individually selected cadence between 60-162 
75 revolutions per minute (rpm). Failure in a test was determined as a drop in cadence exceeding 163 
10 rpm for >5 s. Peak workload was determined according to the point of termination of the 164 
test. V̇O2peak was determined by identifying the highest 15-s mean V̇O2 value recorded before 165 
the participant’s volitional termination of the test. The ventilatory threshold (VT) was 166 
determined as the exercise level at which V̇E/V̇O2 exhibited a systematic exponential increase 167 
without a concomitant increase in V̇E/V̇CO2 (Wasserman et al., 1973), and the deflection point 168 
of carbon dioxide output (V̇CO2) versus O2 uptake (V̇O2; V-slope method) (Amann et al., 2006; 169 
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Beaver et al., 1986). The respiratory compensation point (RCP) was estimated by identifying 170 
the second non-linear increase of V̇E and V̇CO2, whereby an increase in V̇E/V̇O2 was 171 
accompanied by an increase of V̇E/V̇CO2 (Wasserman and McIlroy, 1964).  172 
 173 
2.3. Measurements 174 
During exercise participants wore a facemask to continuously collect expired air using an online 175 
metabolic system (Innocor, Innovision A/S, Odense, Denmark). Analysis of expired air allowed 176 
determination of pulmonary O2 uptake (V̇O2), carbon dioxide output (V̇CO2), minute 177 
ventilation (V̇E) and the respiratory exchange ratio (RER) breath by breath. Heart rate was 178 
recorded every 5 s (Polar S610i, Polar Ltd, Finland), with peak HR defined as the highest heart 179 
rate attained within the last 15 s of the point of termination of the test. Beat-to-beat systolic and 180 
diastolic blood pressure was continuously monitored throughout the exercise protocol using the 181 
volume clamp method at the level of the finger (Finometer, Finepress Medical Systems B.V. 182 
the Netherlands).  MAP was calculated from systolic and diastolic pressures (MAP: 0.33 183 
systolic BP + 0.66 diastolic BP). Peak BP was expressed as the highest 15-second mean 184 
pressure obtained before the participant’s volitional termination of the test.  185 
 186 
A continuous wave NIRS system (Hamamatsu Niro 200Nx; Hamamatsu Photonics, 187 
Hamamatsu, Japan), was used to non-invasively determine the oxygenation status of the right 188 
quadricep’s vastus lateralis (VL) muscle. This was determined using the spatially resolved 189 
spectroscopy (SRS) technique and modified Beer-Lambert (MBL) principle with three 190 
wavelengths of emitting light (λ = 735, 810, and 850 nm). The theoretical basis of NIRS and its 191 
use in exercise measurements have been described in detail elsewhere (Ferrari et al., 2011). 192 
Briefly, this technique estimates the optical density changes of deoxygenated haemoglobin and 193 
myoglobin (HHb+Mb) based on the O2 dependency of absorption changes for near-infrared 194 
light in these proteins.  As the VL muscle is a dominant locomotor muscle during cycling 195 
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(Laplaud et al., 2006), the present study examined the Δ[HHb+Mb]) profiles of the right VL 196 
muscle. After shaving the skin, the probes were placed on the belly of the muscle (5-8 cm above 197 
the lateral femoral condyle), parallel to the major axis of the thigh with a 3 cm spacing between 198 
the emitter and receiver. The probes were housed in a black rubber holder and secured on the 199 
skin surface with bi-adhesive tape and then covered with a dark elastic bandage, which 200 
minimised extraneous movement and the intrusion of stray light throughout the exercise 201 
protocol. Since the depth of the measured area is estimated to be between one-half and one-202 
third of the distance between the emitter and the receiver (~1.5 cm) (Ferrari et al., 2004; Van 203 
Beekvelt et al., 2001), the thickness of the skin and adipose tissue at the site of the probe 204 
placement was measured via 2D ultrasound operating in B-mode (Zonare Ultra Smart Cart, 205 
Software version 4.7, USA). This was to ensure that data largely represented absorption of near-206 
infrared light in muscle tissue and not in subcutaneous fat. 207 
 208 
2.4. Data analysis 209 
2.4.1. Muscle deoxygenation. The NIRS-derived signal was normalised whereby the unloaded 210 
exercise baseline value was adjusted to zero (‘zero set’). Thus the NIRS data are presented as a 211 
relative change from the baseline- to the end-exercise values. As such 0% represents the mean 212 
steady-state value of the last 30 s of the unloaded cycling and 100% represents the highest mean 213 
value of the last 30 s of any work rate. This was done given the uncertainty of the optical path 214 
length in the VL at rest and during exercise, so, data are presented as normalised delta units 215 
Δ[HHb+Mb]. Prior to analysis, NIRS data were averaged to give 1 s intervals. The second-by-216 
second [HHb+Mb] data was averaged by applying a five-point moving average and then 217 
normalised to the peak amplitude of the response (%Δ[HHb+Mb]). The [HHb+Mb] response 218 
dynamics were expressed in relation to relative power output (%PO) prior to curve fitting. 219 
Therefore, individual profiles were plotted as a function of %PO and characterised by a linear 220 
function with two terms to establish the slope of increase of deoxygenation (Slope1), plateau as 221 
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maximal exercise was approached (Slope2), and the break point (BP) located between the 222 
increasing deoxygenation and its plateau. The double linear function was applied using 223 
TableCurve 2D (Systat Software, USA) as: 224 
 225 
y = a + b * x – c * (x-d)*f 226 
 227 
f = if (x<d, 0, 1) 228 
where a and b represent the y-intercept and slope of the first linear function (slope1), d is the 229 
time delay or BP where the segments intersect, with the slope of the second linear function 230 
(slope2) being calculated from the parameter estimates of b and c (slope2 = b - c). 231 
 232 
2.4.2. ΔV̇O2/ΔPO 233 
The rate of change V̇O2 relative to PO during ramp incremental exercise reflects the capacity 234 
of aerobic metabolism to adjust to the non-steady state conditions incurred during a ramp 235 
incremental protocol.  Initially, the mean response time (MRT) of ramp incremental exercise 236 
was estimated using the approach recently described by Iannetta et al. (2019). Briefly, we 237 
determined the average steady-state V̇O2 corresponding to three separate bouts of moderate-238 
intensity constant-power outputs (performed on a separate visit), and we then compared the 239 
ramp-derived power output associated with that V̇O2 to the constant-power output that elicited 240 
that V̇O2 (Iannetta et al., 2019). The difference between these power outputs was converted to 241 
the time to retrieve the time-interval corresponding to MRT.  The breath by breath V̇O2 data 242 
were averaged over 15 s intervals and plotted as a function of work rate after applying the MRT 243 
to reflect the increase in aerobic metabolism (ΔV̇O2) for each increase in power output (ΔPO).  244 
From this the ΔV̇O2/ΔPO slope was calculated over the same range of PO as used to determine 245 
the first %Δ[HHb+Mb]/%PO slope (i.e parameter b or slope1) as described above.  246 
 247 
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2.5. Statistical analyses 248 
Statistical analysis was performed using the software SigmaPlot version 12.5 (Systat Software, 249 
Point Richmond, CA). Prior to analysis, normal Gaussian distribution of the data was assessed 250 
using the Shapiro-Wilk’s test. Physical characteristics and NIRS-derived muscle deoxygenation 251 
responses between groups were compared using unpaired 2-tailed Student’s t-test for 252 
parametric analyses, or the Mann-Whitney U test for non-parametric analyses.  Based on a 253 
priori evidence on the pre-determined reduced functional exercise capacity in individuals with 254 
uncomplicated T2D, the peak physiological responses between groups were compared using 255 
unpaired 1-tailed Student’s t-test for parametric analyses, or the Mann-Whitney U test for non-256 
parametric analyses. Correlations between variables were established using the Peaarson 257 
product-moment correlation coefficient (Pearson r). Statistical significance was accepted at a P 258 
≤ 0.05. All values are expressed as means ± standard deviation (SD) or as median and 259 
interquartile ranges for data that were deemed not normally distributed. 260 
 261 
3. Results 262 
3.1. Physical characteristics and activity levels. 263 
Participants’ physical characteristics and activity levels are shown in Table 1. Both groups were 264 
well matched according to sex, age, body mass and BMI. Inactivity levels did not differ between 265 
groups, but individuals with T2D recorded higher light intensity activity levels. As expected, 266 
participants with T2D displayed higher HbA1c and fasting plasma glucose levels. They also had 267 
higher total cholesterol than the controls. 268 
 269 
3.2. Performance data from ramp incremental cycling test 270 
Relative V̇O2peak (mean difference = 6.14 mL.kg-1.min-1), absolute V̇O2peak (mean difference = 271 
0.42 L.min-1) and peak PO were significantly (P < 0.05) reduced in individuals with T2D 272 
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compared with controls (Table 2). In addition, V̇O2 at VT and V̇O2 at RCP were also 273 
significantly lower in T2D (P < 0.05) compared with controls (Table 2).  274 
 275 
3.3. NIRS-derived [HHb+Mb] response dynamics and correlations 276 
Group mean parameter estimates from the double linear model of the %Δ[HHb+Mb] profile as 277 
a function of normalised power output (%PO) are displayed in Table 3. Individual 278 
representative profiles of the modelled [HHb+Mb] response dynamics as a function of %PO 279 
are displayed in Fig 1, while group mean responses are shown in Fig 2. Due to a technical error 280 
with the NIRS data (i.e. the entire [HHb+Mb] responses were negative instead of positive), data 281 
from 6 participants (3 controls: 2 males, 1 female; and 3 participants with T2D: 2 males, 1 282 
female). were excluded from the analyses. The slope of the first linear regression function 283 
(slope1) used to establish the dynamic adjustment of [HHb+Mb] was significantly steeper (P < 284 
0.05) in participants with T2D than the controls (Table 3, Fig 3). In addition, in T2D slope1 was 285 
significantly correlated with absolute V̇O2peak (r = -0.67, P = 0.009), relative V̇O2peak (r = -0.64; 286 
P = 0.013) and peak PO (r= -0.74; P = 0.003); whereas slope1 was not correlated with these 287 
variables in ND controls (r = 0.132, P = 0.65; r = 0.01, P = 0.97; r = 0.155, P = 0.60; 288 
respectively). Correlations between slope1 and absolute V̇O2peak for both groups are shown in 289 
Fig 4. The exclusion of these 6 participants did not affect the physical characteristics of each 290 
group (i.e. they were matched in terms of age, body composition and activity levels) or the peak 291 
exercise responses between groups.  292 
 293 
3.4. ΔV̇O2/ΔPO  294 
The rate of change in V̇O2/PO was not significantly different during the ramp incremental 295 
exercise between the T2D and ND groups with no observed differences in slopes (9.3  3.4 vs. 296 
9.6  1.1 mL.min-1.W-1 respectively, P = 0.23).  297 
 298 
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4. Discussion 299 
The principal original finding of the present investigation was that individual with T2D 300 
demonstrated a significantly steeper primary slope of the bi-linear regression used to establish 301 
the dynamic adjustment of [HHb+Mb] during a ramp incremental exercise compared with 302 
controls. Concomitant with the reduced (21%) V̇O2peak responses observed in individuals with 303 
T2D compared with controls herein and previously (Baldi et al., 2003; Kiely et al., 2015; Mac 304 
Ananey et al., 2011; O'Connor et al., 2015; O'Connor et al., 2012; Regensteiner et al., 1998), 305 
such adjustment of [HHb+Mb] provides further insight into pathophysiological mechanisms 306 
potentially responsible for the reduced functional capacity in this clinical population. Given that 307 
overall, the objectively measured physical activity levels did not differ between groups, the 308 
exaggerated exercise intolerance is likely not affected by differences in activity levels. 309 
Therefore, in agreement with our hypothesis, the present study suggests that T2D alters the 310 
profile of muscle fractional O2 extraction during ramp incremental cycle exercise. Specifically, 311 
T2D induced a greater reliance on normalized O2 extraction for a given normalized PO up to 312 
the [HHb+Mb]-BP (i.e. larger slope1), and importantly, slope1 was inversely correlated with 313 
peak exercise capacity in participants with T2D.  314 
 315 
Accordingly, the accelerated muscle deoxygenation revealed by the steeper primary 316 
%Δ[HHb+Mb]/%PO slope of the bi-linear regression indicates a reduced capacity to increase 317 
peripheral O2 delivery to meet increasing O2 demands. The expression of this response in 318 
relation to the absolute workload may provide misleading conclusions given a diseased 319 
population with an established exercise intolerance (i.e. lower peak PO) is being compared to 320 
a healthy, albeit obese, population. A steeper adjustment of Δ[HHb+Mb] would be expected in 321 
participants with T2D given their lower peak PO during the ramp incremental test.  Thus, it is 322 
warranted to make comparisons amongst these populations in the context of relative intensity 323 
(i.e. as a function of PO%) (Murias et al., 2013). A reduced PmvO2 and intracellular PO2 will 324 
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radically impact muscle metabolism by reducing [phosphocreatine] and elevating [ADP]free, 325 
[Pi], [H+] and [NADH].  This increased glycolysis will rely on finite glycogen stores 326 
culminating in premature muscular fatigue and ultimately increased exercise intolerance in this 327 
clinical population. It should be noted that owing to the generation of noisy V̇O2 data in some 328 
of the participants, in the present study we were unable to assess the relationship of 329 
%Δ[HHb+Mb] with %V̇O2.responses. 330 
 331 
These findings are in accordance with studies whereby O2 availability during incremental 332 
exercise is deliberately compromised. Specifically, where O2 delivery was manipulated via 333 
exercising in the supine posture and subsequently reducing perfusion pressure (DiMenna et al., 334 
2010; Egaña et al., 2013). In particular, DiMenna et al. (2010) demonstrated a significantly 335 
steeper slope of the %Δ[HHb+Mb]/%PO sigmoidal response profile in the supine compared 336 
with upright posture during a ramp incremental exercise, implying a greater reliance on O2 337 
extraction for the same PO (DiMenna et al., 2010). Similarly, Behnke et al. (2002) reported 338 
Pmvo2 reductions at a given muscle stimulation intensity in the GK rodent model of T2D 339 
compared with healthy controls predicating either a reduced O2 diffusion across the capillary-340 
myocyte space to the mitochondria or a lowered intramyocyte PO2 which would impair muscle 341 
metabolism and function (Behnke et al., 2002). Thus, the findings of the present study combined 342 
with the previously reported blunted microvascular blood flow responses at the onset of 343 
moderate-intensity cycling exercise in individuals with uncomplicated T2D (Bauer et al., 2007), 344 
strengthens the argument for reduced O2 delivery as a likely source of impairment in V̇O2 345 
control in this population. 346 
 347 
With evidence of an imbalance in QO2 relative to PO within the microvasculature during ramp 348 
incremental exercise in T2D, and the resultant lowered Pmvo2, an impaired haemodynamic 349 
response can be posited as a potential mechanistic basis for the diminished exercise capacity 350 
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herein. Indeed, the significant correlations observed between the initial slope of muscle 351 
deoxygenation with V̇O2peak and peak PO in the group with T2D support this notion. In this 352 
regard, the attenuated hyperaemic and haemodynamic response during maximum graded calf 353 
plantar flexion exercise demonstrated by this clinical population (Kiely et al., 2014) is of 354 
relevance. Specifically, Kiely et al. (2014) demonstrated that peak leg blood flow and the slope 355 
of leg blood flow relative to percentage peak force during an incremental calf exercise were 356 
significantly blunted in men and women with T2D. These reductions were accompanied by 357 
significantly lower (magnitude of ~15%) peak force relative to MVC during the calf graded 358 
test, which also coincided with a significant (~15%) reduction in V̇O2peak during a graded 359 
cycling test in the same participants (Kiely et al., 2014). Therefore, the demonstration in the 360 
present study of a faster rise in the primary linear %Δ[HHb+Mb]/%PO signal (slope1) in T2D 361 
compared with controls, combined with a similar rate of increase in V̇O2 relative to PO (i.e. 362 
ΔV̇O2/ΔPO) extends the findings of a dampened hyperaemic response previously observed in 363 
isolated muscle groups to that of whole body exercise in uncomplicated T2D.  364 
 365 
Although the mechanisms responsible for the altered profile of muscle fractional O2 extraction 366 
observed in individuals with T2D were not directly explored in this study, the impaired vascular 367 
function extensively evidenced in T2D is a likely culprit. For instance,  attenuated endothelium-368 
dependent vasodilation of resistance vessels in both, the resting forearm (McVeigh et al., 1992; 369 
Williams et al., 1996), and the lower limb during cycle exercise (Kingwell et al., 2003) have 370 
been reported in individuals with uncomplicated T2D compared to controls. In addition 371 
tempered vasodilator responses of the vascular smooth muscle elicited subsequent to 372 
exogenous, direct-acting nitric oxide (NO) donors in the form of glyceryl trinitrate (McVeigh 373 
et al., 1992) and sodium nitroprusside (Kingwell et al., 2003; Williams et al., 1996) have also 374 
been reported in the respective T2D cohorts. It is pertinent to acknowledge, however, that in 375 
the absence of cardiac output (CO) data, we cannot exclude the possibility that impairments in 376 
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cardiac function (Joshi et al., 2010; Regensteiner et al., 2009; Wilson et al., 2017a; Wilson et 377 
al., 2017b) could induce subsequent regional O2 delivery impediments; although peak CO is 378 
not significantly reduced in uncomplicated T2D (Baldi et al., 2003; Regensteiner et al., 2009). 379 
Moreover, factors beyond convective and diffusive O2 delivery may also be involved given that 380 
structural changes in the skeletal muscles of individuals with T2D havae been observed. 381 
Specifically, reductions in mitochondrial content (~30%) (Boushel et al., 2007; Ritov et al., 382 
2005) and functional capacity (~40%) (Kelley et al., 2002; Ritov et al., 2005), as well as 383 
alterations in muscle fibre type (Marin et al., 1994), having an approximate 2-fold increase in 384 
type IIb fibres relative to type I (Mogensen et al., 2007) have been reported in T2D, although 385 
the functional evidence for this notion is unclear (Rabol et al., 2006). 386 
 387 
Limitations of the present study should be acknowledged. Firstly, given the functional 388 
limitations of the NIRS technology utilised herein, we were unable to make direct comparisons 389 
of absolute concentration and changes in Δ[HHb+Mb] between individuals with and without 390 
T2D. However, [HHb+Mb] possesses a time course similar to fractional O2 extraction (Koga et 391 
al., 2012). Secondly, the present findings relate to the evaluation of a single muscle, the VL, 392 
and as such, cannot wholly represent the skeletal muscle blood flow response to exercise. Also, 393 
the heterogeneity within an individual muscle is recognised; structurally, pertaining to 394 
vascularity and fibre type (Johnson et al., 1973), and functionally, relating to fibre recruitment, 395 
vascular control and blood flow (Behnke et al., 2003; Koga et al., 2011; McDonough et al., 396 
2005).  Thirdly, adipose tissue thickness at the site of measurement has the potential to influence 397 
NIRS measurements through its effect on the scattering properties of the tissue. As such, the 398 
thickness of the skin and adipose tissue was measured at the site of the interrogation via 2D 399 
ultrasound operating in B-mode, with no differences revealed between groups. The current 400 
findings are applicable to individuals <55 yr, so, future studies should assess if these effects are 401 
also apparent in older people with T2D. 402 
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 403 
5. Conclusions 404 
The findings from the present study offer an insight into potential contributory mechanisms for 405 
the consistently observed reduction in exercise capacity in T2D. The demonstration of a greater 406 
rate of O2 extraction for a given increase in PO suggests that a reduced O2 delivery within the 407 
microvasculature is an important underlying cause of exercise intolerance during a maximum 408 
graded test in T2D. This observation strengthens the notion that factors beyond central control 409 
also contribute to the diminished exercise tolerance of this clinical population. Such factors are 410 
most likely attributed to impairments in active muscle microvascular perfusion. Thus, exercise 411 
training interventions designed to benefit exercise tolerance in T2D should also focus on 412 
microvascular O2 delivery.  413 
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 597 
Figure captions 598 
Figure 1: Representative profiles of the modelled [HHb+Mb] response dynamics during ramp 599 
incremental exercise for an individual without, and an individual with T2D when expressed as 600 
a function of relative power output (PO%). Double-linear regression models are superimposed 601 
on the data. The first %Δ[HHb+Mb]/%PO slope of the double linear regression is indicated 602 
beside each curve. Note the relatively larger slope in the participant with T2D compared with 603 
the control participant.    604 
 605 
Figure 2: Group mean ± SD normalised [HHb+Mb] responses as a function of relative power 606 
output (PO%). Data are shown at 10% PO intervals. Note the relatively steeper increase in 607 
[HHb+Mb] in the group with T2D compared with the control group.    608 
 609 
Figure 3: Individual and mean ± SD (bar graph) responses of the first %Δ[HHb+Mb]/%PO 610 
slope (Slpoe1) of the double linear regression in the T2D and control groups.  611 
 612 
Figure 4: Relationships between first %Δ[HHb+Mb]/%PO slope (Slpoe1) of the double linear 613 
regression and V̇O2peak (mL.kg-1.min-1) in participants with T2D and ND controls.   614 
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Alternative Fig 4 (no regression line in control 623 
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Table 1. Physical characteristics and activity levels. 626 
 ND T2D P value 
n 17 17  
Physical characteristics    
   Sex (male, female) 12, 5 12, 5  
   Age (yr) 44 ± 8 48 ± 7 0.13 
   BMI (kg.m-2) 30.8 ± 3.5 31.9 ± 4.8 0.46 
   Body Mass (kg) 91.1 ± 13.8 95.8 ± 18.3 0.40 
   HbA1c (%)a 5.1 (0.5)* 6.8 (0.9) <0.001 
   FPG (mmol.L-1)b 4.0 (0.4)* 7.4 (2.9) <0.001 
   Fat layer VL (mm)c 7.8 ± 4.5 5.9 ± 1.6 0.14 
   Time since diagnosis (yr)  5.7 ± 3.7  
   Total cholesterol (mmol.L-1)d 3.6 ± 0.9* 4.4 ± 0.7 0.03 
   LDL-C (mmol.L-1)e 2.0 ± 0.7 2.2 ± 0.7 0.50   
   HDL-C (mmol.L-1)d 1.2 ± 0.2 1.35 ± 0.3 0.62 
   Triglycerides (mmol.L-1)f 1.1 (0.9)† 1.5 (1.3) 0.08 
Habitual physical activity    
   Inactive (h.day-1)g        18.9 ± 1.3 18.0 ± 1.0         0.15 
   Light (h.day-1)g 4.2 ± 1.0* 5.3 ± 1.1 0.05 
   Moderate (h.day-1)g 0.7 ± 0.4 0.6 ± 0.6 0.69 
   Vigorous (h.day-1)g 0.2 (0.2) 0.1 (0.1) 0.17 
 627 
Mean ± SD values are shown in normal font for variables which were normally 628 
distributed; whereas median (and interquartile range) values are shown in italic font for 629 
variables which showed significant skewness and were not normally distributed in one 630 
or both groups. BMI, body mass index; HbA1c, glycosylated haemoglobin; FPG, fasting 631 
plasma glucose; VL, vastus lateralis; LDL-C, low-density lipoprotein cholesterol; HDL-632 
C, high-density lipoprotein cholesterol. Some variables have missing values and the 633 
sample sizes with codes are shown below. *Significantly different than T2D (P ≤ 0.05). 634 
†Tendency towards a difference than T2D (P ≤ 0.10). 635 
a = 7 (ND) and 15 (T2D); b = 10 (ND) and 13 (T2D); c = 13 (ND) and 15 (T2D); d=10 636 
(ND) and 12 (T2D); e = 10 (ND) and 10 (T2D); f = 10 (ND) and 13 (T2D); g = 13 (ND) 637 
and 6 (T2D). 638 
 639 
  640 
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Table 2. Physiological responses to the ramp incremental test.  641 
 
ND T2D 
 
P value 
n 17 17  
V̇O2peak (mL.kg-1.min-1) 28.62 ± 5.50* 22.48 ± 3.65 <0.001 
V̇O2peak (L.min-1) 2.60 ± 0.58* 2.18 ± 0.65 0.03 
Peak PO (W) 196 (108)* 186 (106) 0.04 
Peak HR (beats.min-1) 175 (27)* 165 (26) 0.04 
Peak RER (a.u.) 1.2 (0.1) 1.1 (0.1) 0.20 
Peak MAP (mmHg)a 126 ± 17 137 ±24 0.14 
Peak SBP (mmHg)a 170 ± 24* 187 ± 19 0.05 
Peak DBP (mmHg)a 103 ± 16 103 ± 23 0.48 
V̇O2 at VT (W) 1.78 ± 44* 1.55 ± 0.47 0.02 
V̇O2 at RCP (W) 2.25 ± 0.49* 1.93 ± 0.57 0.04 
    
Mean ± SD values are shown in normal font for variables which were normally distributed; 642 
whereas median (and interquartile range) values are shown in italic font for variables which 643 
showed significant skewness and were not normally distributed in one or both groups. V̇O2, 644 
volume of oxygen uptake; PO, power output; HR, heart rate; RER, respiratory exchange ratio; 645 
MAP, mean arterial pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; VT, 646 
ventilatory threshold; RCP, respiratory compensation point.  Some variables have missing 647 
values and the sample sizes with codes are shown below. *Significantly different than T2D (P 648 
≤ 0.05).  649 
a = 9 (ND) and 12 (T2D).  650 
 651 
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Table 3. Parameter estimates for the %Δ[HHb+Mb] profile for both groups plotted as a 653 
function of normalised PO (%) during the ramp incremental test. 654 
 655 
 
ND T2D 
 
P value 
n 14 14  
b (slope1) 1.35 (0.43)* 1.81 (0.61) 0.02 
b - c (slope2) 0.15 ± 0.67 -0.21 ± 0.57 0.14 
BP (%) 81.2 ± 11.9 75.2 ± 12.5 0.20 
 656 
Mean ± SD values are shown in normal font for variables which were normally distributed; 657 
whereas median (and interquartile range) values are shown in italic font for variables which 658 
showed significant skewness and were not normally distributed in one or both groups. Slope1 659 
and Slope2 of linear regression before and after breakpoint (BP) respectively.*Significantly 660 
different than T2D (P < 0.05).  661 
 662 
 663 
 664 
 665 
